Developments in neuroradiological MRI analysis offer promise in enhancing objectivity and
consistency in dementia diagnosis through the use of quantitative volumetric reporting tools …

We performed a systematic review of studies focusing on the automatic prediction of the
progression of mild cognitive impairment to Alzheimer's disease (AD) dementia, and a …

Over the past decade, machine learning (ML) and artificial intelligence (AI) have become
increasingly prevalent in the medical field. In the United States, the Food and Drug …

Importance Brain atrophy and vascular lesions contribute to dementia and mild cognitive
impairment (MCI) in clinical referral populations. Prospective evidence in older general …

Background One significant barrier to incorporate Alzheimer's disease (AD) imaging
biomarkers into diagnostic criteria is the lack of standardized methods for biomarker …

Alzheimer's Disease (AD) exerts a significant worldwide impact. An estimated 44 million
individuals currently live with this Major Neurocognitive Disorder. There are about 6.2 million …

There is a growing literature on the impact of ethnicity on brain structure and function.
Despite the regional heterogeneity in age-related changes and non-uniformity across brain …

Background Different clinically feasible methods for evaluation of medial temporal lobe
atrophy exists and are useful in diagnostic work-up of Alzheimer's disease (AD). Purpose To …

Objective To compare two clinically available MR volumetry software, NeuroQuant®(NQ)
and Inbrain®(IB), and examine the inter-method reliabilities and differences between them …

Background PET can be used for amyloid-tau-neurodegeneration (ATN) classification in
Alzheimer disease, but incurs considerable cost and exposure to ionizing radiation. MRI …